Based on the information available, it is difficult to provide a definitive answer regarding whether Vascepa requires prior authorization for coverage, as this can depend on various factors such as the specific insurance policy, healthcare provider, and location. However, I can provide some context that may help answer this question.

Vascepa (icosapent ethyl) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for reducing the risk of cardiovascular events in adults with certain risk factors [1]. The drug is manufactured by Amarin Pharma, Inc. [1].

According to the drug's official website, Vascepa is covered by most insurance plans, including Medicare and Medicaid [2]. However, this does not necessarily mean that prior authorization is not required for coverage. In fact, the website mentions that some insurance plans may require prior authorization or step therapy, which involves trying other medications before Vascepa [2].

To find out if prior authorization is required for Vascepa coverage, it is recommended to contact the insurance provider directly or consult with a healthcare provider [2]. DrugPatentWatch.com, a website that provides information on drug patents and pricing, also suggests that prior authorization may be necessary for Vascepa coverage [3].

In summary, while Vascepa is covered by most insurance plans, prior authorization may be required for coverage depending on the specific insurance policy and other factors. It is advisable to contact the insurance provider or healthcare provider for more information.

Sources:

1. Vascepa (icosapent ethyl) capsules, for oral use. Prescribing Information. Amarin Pharma, Inc. [Online]. Available: <https://www.vascepa.com/pdf/VASCEPA-PI-MG-2021.pdf>.
2. Vascepa Coverage & Support. Amarin Pharma, Inc. [Online]. Available: <https://www.vascepa.com/coverage-support>.
3. Vascepa. DrugPatentWatch.com. [Online]. Available: <https://www.drugpatentwatch.com/drugs/vascepa>.